References

Dermal fillers: an update

10.1007/s40257-015-0135-7 · 2015 · External reference

Serious complications of hyaluronic acid fillers—A retrospective study of 290,307 cases

10.1097/sap.0000000000004327 · 2025 · External reference

Complications and litigation associated with injectable facial fillers: a cross-sectional study

10.1016/j.joms.2019.08.003 · 2020 · External reference

Analysis of US Food and Drug Administration data on soft-tissue filler complications

10.1097/dss.0000000000002208 · 2020 · External reference

Postmarket safety surveillance of delayed complications for recent FDA-approved hyaluronic acid dermal fillers

10.1097/dss.0000000000003350 · 2022 · External reference

Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers—Evidence-and opinion-based review and consensus recommendations

10.1097/prs.0000000000002184 · 2016 · External reference

Adverse events in nonsurgical facial aesthetic procedures: a systematic review and meta‐analysis

10.1111/odi.70109 · 2026 · External reference

Treatment of injection‐induced ecchymoses with light/laser‐assisted technology

10.1111/dth.12861 · 2019 · External reference

Perioperative management of and recommendations for antithrombotic medications in dermatological surgery

10.1111/bjd.13362 · 2015 · External reference

Purpura and fillers: a review of pre-procedural, intra-procedural, and post-procedural considerations

2013 · External reference

Myth versus reality: a review of social media claims and scientific evidence for Arnica montana in postinjectable procedures

2022 · External reference

Is there a role for arnica and bromelain in prevention of post-procedure ecchymosis or edema? A systematic review of the literature

10.1097/dss.0000000000000701 · 2016 · External reference

Safety assessment of high‐and low‐molecular‐weight hyaluronans (Profhilo) as derived from worldwide postmarketing data

10.1155/2020/8159047 · 2020 · External reference

Post filler ecchymosis resolution with intense pulsed light

2018 · External reference

New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events

10.1093/asj/sjw251 · 2017 · External reference

Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique

10.1016/j.jaad.2017.01.035 · 2017 · External reference

Expert consensus on clinical recommendations for fractional ablative CO2 laser, in facial skin rejuvenation treatment

10.1002/lsm.23850 · 2025 · External reference

Complication management following rejuvenation procedures with hyaluronic acid fillers—an algorithm-based approach

10.1097/gox.0000000000002061 · 2018 · External reference

Ultrasonographic features of nonvascular complications of hyaluronic acid fillers: a retrospective study at a reference center for dermatologic ultrasonography

10.1016/j.clindermatol.2024.05.006 · 2024 · External reference

Adverse reactions to injectable fillers

10.1055/s-0036-1592340 · 2016 · External reference

A systematic review supporting the American Society for Dermatologic Surgery Guidelines on the prevention and treatment of adverse events of injectable fillers

10.1097/dss.0000000000002911 · 2021 · External reference

An overview of infections associated with soft tissue facial fillers: identification, prevention, and treatment

10.1016/j.joms.2016.09.004 · 2017 · External reference

Bacterial biofilm formation and treatment in soft tissue fillers

10.1111/2049-632x.12139 · 2014 · External reference

Biofilm formation is a risk factor for late and delayed complications of filler injection

10.3389/fmicb.2023.1297948 · 2023 · External reference

The role of bacterial biofilm in adverse soft-tissue filler reactions: a combined laboratory and clinical study

10.1097/prs.0000000000003067 · 2017 · External reference

Mycobacterium chelonae facial infections following injection of dermal filler

10.1177/1090820x12471944 · 2013 · External reference

A treatment algorithm for hyaluronic acid filler related complications of the face

10.1016/j.bjps.2024.02.010 · 2024 · External reference

Fluoroquinolones for dermatologists: a practical guide to clinical use and risk management

10.3390/ph18060800 · 2025 · External reference

Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review

10.1016/j.ijid.2024.107259 · 2024 · External reference

Granulomas and nongranulomatous nodules after filler injection: different complications require different treatments

10.1016/j.bjps.2020.08.012 · 2020 · External reference

Oral/perioral reactions to injectable soft tissue fillers: a clinicopathological multicentric study

10.1111/odi.15143 · 2025 · External reference

Filler migration: a number of mechanisms to consider

10.1097/iop.0000000000000368 · 2015 · External reference

Post-treatment displacement of facial soft tissue fillers—a retrospective ultrasound-based investigation of 382 zygomatic regions

10.1097/dss.0000000000004257 · 2024 · External reference

Filler migration to the orbit

10.1093/asj/sjaa264 · 2021 · External reference

A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment

10.1097/prs.0b013e31829e52a7 · 2013 · External reference

Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations

10.1097/01.dss.0000452646.76270.53 · 2014 · External reference

Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management

10.1097/dss.0000000000000418 · 2015 · External reference

Making sense of late tissue nodules associated with hyaluronic acid injections

10.1093/asj/sjad028 · 2023 · External reference

Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients

10.1016/j.jaad.2020.01.066 · 2020 · External reference

Preventing and treating adverse events of injectable fillers: evidence-based recommendations from the American Society for Dermatologic Surgery Multidisciplinary Task Force

10.1097/dss.0000000000002921 · 2021 · External reference

Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment

10.1097/dss.0000000000001814 · 2019 · External reference

Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options

10.1097/prs.0b013e3181858f4f · 2009 · External reference

Minimally invasive treatment for facial injection infection

10.1097/scs.0000000000011744 · 2025 · External reference

Colchicine in contemporary pharmacotherapy: mechanistic insights and clinical Horizons

10.3390/jcm14197078 · 2025 · External reference

Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients

10.1111/j.1524-4725.2009.01347.x · 2009 · External reference

COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment

10.1007/s00403-021-02190-6 · 2022 · External reference

Clinical updates of JAK inhibitors in cutaneous granulomatous diseases

10.3389/fimmu.2025.1698816 · 2025 · External reference

Post-hyaluronic acid filler reaction treated with abrocitinib: a case report

10.36849/jdd.7271 · 2024 · External reference

Understanding vascular complications arising from dermal filler injection

10.1097/scs.0000000000011175 · 2025 · External reference

Critical ischemia following hyaluronic acid filler injection: a case report

10.3390/jcm14030802 · 2025 · External reference

Guide for managing vascular occlusion caused by fillers with exclusive cutaneous involvement: a review of diagnosis, classification, and treatment

10.1007/s00266-025-05104-3 · 2026 · External reference

Reviewing the role of angiosomes in filler-induced tissue necrosis: observed patterns and clinical signs

2022 · External reference

Ultrasound patterns of different dermal filler materials used in aesthetics

10.1111/jocd.14032 · 2021 · External reference

Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers

10.1016/j.jaad.2019.07.032 · 2023 · External reference

Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol

2021 · External reference

Anesthesia for vascular access surgery

10.5301/jva.5000233 · 2014 · External reference

Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG imaging

10.1097/iop.0000000000000446 · 2016 · External reference

Consensus guidelines for the management of tissue filler-induced vision loss in the United Kingdom

10.1093/asj/sjag002 · 2026 · External reference

A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management

10.1093/asj/sjz312 · 2020 · External reference

Vision-threatening complications of soft tissue fillers: a report by the American Academy of Ophthalmology

10.1016/j.ophtha.2025.01.020 · 2025 · External reference

Update on blindness from filler: review of prognostic factors, management approaches, and a century of published cases

10.1093/asj/sjae091 · 2024 · External reference

EYE‐CODE protocol for the nonophthalmologist for treatment of retinal artery occlusion after intra‐arterial injection of soft‐tissue fillers: 2025 update

10.1111/jocd.70336 · 2025 · External reference

Cosmetic filler-induced hair loss: case series and literature review

10.1080/09546634.2024.2443111 · 2024 · External reference

Dermal filler‐induced alopecia: a case report and literature review

10.1111/jocd.16684 · 2025 · External reference

Rates of vascular occlusion associated with using needles vs cannulas for filler injection

10.1001/jamadermatol.2020.5102 · 2021 · External reference

Arterial wall forces in needles versus cannulas

10.1097/prs.0000000000005321 · 2019 · External reference

Hyaluronidase: from clinical applications to molecular and cellular mechanisms

10.1186/s40001-016-0201-5 · 2016 · External reference

Comparison of the degradability of hyaluronic acid by ovine and recombinant human hyaluronidase

10.1093/asj/sjaf127 · 2025 · External reference

Use of hyaluronidase in plastic surgery: a review

10.1016/j.bjps.2021.03.125 · 2021 · External reference

Allergic complications of hyaluronidase injection: risk factors, treatment strategies, and recommendations for management

10.1007/s00266-023-03348-5 · 2024 · External reference